Loading Antiseizure Medications: The Nurse's Role in Stopping Status

Part of the ICU Emergencies Hub — browse every related guide in one place.

Updated July 2026  |  More ICU clinical guides →

In status epilepticus, the drugs work in a defined sequence and time is the enemy — every minute a seizure continues, it becomes harder to stop and more likely to injure the brain. The nurse is the one who draws up the benzodiazepine, gets the second-line load hung, controls the infusion rate, and watches for the hemodynamic and airway consequences that these drugs bring. This guide walks through the standard treatment ladder, the second-line agents and how they differ, and the specific monitoring a nurse owns during a load. Doses vary by protocol and patient — always follow your facility's orders and pharmacy; the numbers here are typical adult reference ranges to frame the concepts.

First-line: the benzodiazepine, dosed adequately

Benzodiazepines abort most seizures if given fast and at the right dose. The common failure is timidity — repeated tiny doses that never reach a therapeutic level. Typical first-line options are IV lorazepam (often 4 mg, repeated once), IM midazolam (10 mg for adults with no IV, and as effective as IV in the prehospital setting), or IV diazepam. If the first adequate dose does not stop the seizure, a second dose is given, and the team moves promptly to a second-line agent — you do not keep stacking benzodiazepines indefinitely. Watch for the predictable consequences: respiratory depression and sedation, so airway equipment and monitoring are ready before you push.

Second-line: the antiseizure load

When benzodiazepines fail, one of three intravenous antiseizure medications is loaded. Large trials found them broadly comparable in stopping established status, so the choice often comes down to the patient's comorbidities, drug interactions, and what your unit stocks. Each has a distinct safety profile the nurse must respect at the bedside.

Levetiracetam

Levetiracetam (Keppra) is frequently first-reached for because it is easy to give, has minimal cardiovascular effects, and few drug interactions. It infuses relatively quickly. The main things to watch are behavioral — sedation, and occasionally agitation or irritability.

Fosphenytoin and phenytoin

Fosphenytoin is the prodrug of phenytoin and is dosed in phenytoin-equivalents (PE); it can be given faster and with less infusion-site injury than phenytoin itself. Both are rate-limited because rapid infusion causes hypotension and bradycardia — keep the patient on a cardiac monitor and slow or stop for hemodynamic change. Phenytoin is notorious for extravasation and "purple glove syndrome," must run in saline (it precipitates in dextrose), and needs a well-functioning line. Levels are followed after loading.

Valproate

Valproate (valproic acid) is a good option, particularly when the seizure type or patient favors it, and it is generally hemodynamically well tolerated. Avoid it in hepatic disease and in pregnancy (teratogenic), and be alert to thrombocytopenia and hyperammonemia; it interacts with several drugs.

Refractory status: continuous infusions

If seizures persist after an adequate benzodiazepine and a second-line load, the patient is in refractory status epilepticus, and treatment escalates to continuous IV infusions — commonly midazolam or propofol (sometimes pentobarbital) — titrated to a continuous EEG target, often seizure suppression or burst-suppression. These patients are almost always intubated, and the nurse manages deep sedation, hemodynamics (propofol and midazolam both lower blood pressure; watch for propofol-related infusion syndrome with high-dose, prolonged propofol), and the EEG correlation that guides titration. Weaning is done carefully with EEG to confirm seizures do not return.

Where to go from here

Pair this with the status epilepticus guide for the full treatment timeline, the nonconvulsive status and cEEG guide for the seizures that continue silently, the seizure precautions and postictal care guide for bedside safety, and the ICU sedation and analgesia guide for managing the continuous infusions in refractory status.